Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis

被引：158
|
作者：
Giles, JT [1 ]
Bartlett, SJ [1 ]
Gelber, AC [1 ]
Nanda, S [1 ]
Fontaine, K [1 ]
Ruffing, V [1 ]
Bathon, JM [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2006年 / 55卷 / 02期
关键词：
D O I：
10.1002/art.21841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：333 / 337
页数：5
相关论文
共 50 条
  • [1] Tumor necrosis factor inhibitor therapy for rheumatoid arthritis
    Naguwa, SM
    [J]. AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 709 - 715
  • [2] Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis
    Katikireddi, Veera S.
    Whittle, Samuel L.
    Hill, Catherine L.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2010, 13 (01) : 12 - 26
  • [3] Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis
    Segal, Barbara
    Rhodus, Nelson L.
    Patel, Ketan
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 106 (06): : 778 - 787
  • [4] Acquired Factor VIII Inhibitor in a Patient of Rheumatoid Arthritis on Tumor Necrosis Factor Inhibitor Therapy
    Mori, Tomoyo
    Watanabe, Naoki
    Kitahara, Hideaki
    Iwao, Noriaki
    Koike, Michiaki
    Komatsu, Norio
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (01) : 192 - 193
  • [5] Acquired Factor VIII Inhibitor in a Patient of Rheumatoid Arthritis on Tumor Necrosis Factor Inhibitor Therapy
    Tomoyo Mori
    Naoki Watanabe
    Hideaki Kitahara
    Noriaki Iwao
    Michiaki Koike
    Norio Komatsu
    [J]. Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 192 - 193
  • [6] The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea
    Jeon, Ha-Lim
    Kim, Seoyoung C.
    Park, So-Hee
    Shin, Ju-Young
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 362 - 363
  • [7] The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea
    Jeon, Ha-Lim
    Kim, Seoyoung C.
    Park, So-Hee
    Shin, Ju-Young
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (05) : 989 - 995
  • [8] A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients
    Fu, Bo
    Lunt, Mark
    Galloway, James
    Dixon, Will
    Hyrich, Kimme
    Symmons, Deborah
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (02) : 461 - 476
  • [9] Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
    Schneeweiss, Sebastian
    Setoguchi, Soko
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Sax, Paul E.
    Levin, Raisa
    Solomon, Daniel H.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1754 - 1764
  • [10] Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
    Perpetuo, Ines P.
    Caetano-Lopes, Joana
    Rodrigues, Ana Maria
    Campanilho-Marques, Raquel
    Ponte, Cristina
    Canhao, Helena
    Ainola, Mari
    Fonseca, Joao E.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
12345